Other Exceptional Opportunities

Use of Human-Relevant Test Methods in Preclinical Testing

Oncology drugs have one of the highest failure rates in clinical trials. Investment in and use of modern, human-relevant preclinical test methods will increase translation to the clinic and the likelihood of success of novel new cancer drugs.

Voting

0 votes
Ideate
Idea No. 767